ÀÛ¼ºÀÏ : 25-07-03 11:19
2025³âµµ ½Å¾à°³¹ß¿¬±¸¼Ò & GIB-RLRC & BK21 °øµ¿ ÁÖÃÖ ¼¼¹Ì³ª ¾È³»
 ±Û¾´ÀÌ : ½Å¾à°³¹ß¿¬±¸¼Ò
Á¶È¸ : 19  
°¡. Çà »ç ¸í: 2025³âµµ °­¿ø´ëÇб³ ½Å¾à°³¹ß¿¬±¸¼Ò & GIB-RLRC & BK21 °øµ¿ ÁÖÃÖ ¼¼¹Ì³ª

³ª. ÀÏ ½Ã: 2025.07.10.(¸ñ) 14:00~16:00

´Ù. Àå ¼Ò: °­¿ø´ëÇб³ Çõ½ÅÁ¦¾àÀӻ󿬱¸µ¿ 103È£

¶ó. ÃÊû¿¬»ç ¹× ¹ßÇ¥³»¿ë
  1£© Yuji Ito ¹Ú»ç£¨Kagoshima Univ., ÀϺ» Ç×üÇÐȸ ȸÀ壩
      - Next-generation ADC by tissue–delivery antibody AccumBody and conjugation technology tCAP
  2£© Yoshimasa Tanaka ¹Ú»ç£¨Nagasaki Univ., PD-1/PD-L1 ±â¹Ý ¸é¿ªÇ×¾ÏÁ¦ °³¹ß ¿¬±¸ Âü¿©£©
      - Cancer immunotherapy harnessing innate immune cells

¸¶. ÁÖ°ü: °­¿ø´ëÇб³ ½Å¾à°³¹ß¿¬±¸¼Ò, GIB-RLRC ¹ÙÀÌ¿À ½Å¾à Çõ½Å¼ÒÀç À¶ÇÕ¼±µµ¿¬±¸¼¾ÅÍ, BK21 ³­Ä¡¼ºÁúȯ Çõ½Å½Å¾à °³¹ß ¹Ì·¡ÀÎÀç±³À°¿¬±¸ÆÀ